Fundies.
English

Segment disclosures

Company overview

AFFYMETRIX INC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

6 dimension combinations 52 retained observations 15 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Affymetrix Core

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=affx:AffymetrixCoreMember
PeriodValueUnitFiledEvidence
2015-01-01 – 2015-12-31261733000 USD20160218Open filing evidence
2015-07-01 – 2015-09-3061689000 USD20151029Open filing evidence
2015-01-01 – 2015-09-30191173000 USD20151029Open filing evidence
2015-04-01 – 2015-06-3065038000 USD20150730Open filing evidence
2015-01-01 – 2015-06-30129484000 USD20150730Open filing evidence
2015-01-01 – 2015-03-3164445000 USD20150430Open filing evidence
2014-01-01 – 2014-12-31256525000 USD20160218Open filing evidence
2014-07-01 – 2014-09-3064645000 USD20151029Open filing evidence
2014-01-01 – 2014-09-30186177000 USD20151029Open filing evidence
2014-04-01 – 2014-06-3062085000 USD20150730Open filing evidence
2014-01-01 – 2014-06-30121532000 USD20150730Open filing evidence
2014-01-01 – 2014-03-3159447000 USD20150430Open filing evidence
2013-01-01 – 2013-12-31241450000 USD20160218Open filing evidence
2013-07-01 – 2013-09-3058178000 RestatedUSD20141030Open filing evidence
2013-01-01 – 2013-09-30171335000 RestatedUSD20141030Open filing evidence
2013-04-01 – 2013-06-3057237000 USD20140804Open filing evidence
2013-01-01 – 2013-06-30113157000 USD20140804Open filing evidence
2013-01-01 – 2013-03-3155920000 USD20140505Open filing evidence
2012-07-01 – 2012-09-3062046000 USD20131104Open filing evidence
2012-01-01 – 2012-09-30192320000 USD20131104Open filing evidence

Operating Segments · Ebioscience

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=affx:EbioscienceMember
PeriodValueUnitFiledEvidence
2015-01-01 – 2015-12-3198053000 USD20160218Open filing evidence
2015-07-01 – 2015-09-3024841000 USD20151029Open filing evidence
2015-01-01 – 2015-09-3073041000 USD20151029Open filing evidence
2015-04-01 – 2015-06-3023928000 USD20150730Open filing evidence
2015-01-01 – 2015-06-3048200000 USD20150730Open filing evidence
2015-01-01 – 2015-03-3124272000 USD20150430Open filing evidence
2014-01-01 – 2014-12-3192494000 USD20160218Open filing evidence
2014-07-01 – 2014-09-3022441000 USD20151029Open filing evidence
2014-01-01 – 2014-09-3069312000 USD20151029Open filing evidence
2014-04-01 – 2014-06-3023347000 USD20150730Open filing evidence
2014-01-01 – 2014-06-3046871000 USD20150730Open filing evidence
2014-01-01 – 2014-03-3123524000 USD20150430Open filing evidence
2013-01-01 – 2013-12-3188949000 USD20160218Open filing evidence
2013-07-01 – 2013-09-3022176000 RestatedUSD20141030Open filing evidence
2013-01-01 – 2013-09-3066428000 RestatedUSD20141030Open filing evidence
2013-04-01 – 2013-06-3022227000 USD20140804Open filing evidence
2013-01-01 – 2013-06-3044252000 USD20140804Open filing evidence
2013-01-01 – 2013-03-3122025000 USD20140505Open filing evidence
2012-07-01 – 2012-09-3017578000 USD20131104Open filing evidence
2012-01-01 – 2012-09-3018953000 USD20131104Open filing evidence

Affymetrix Core

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=affx:AffymetrixCoreMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-31256525000 USD20150218Open filing evidence
2013-01-01 – 2013-12-31241450000 RestatedUSD20150218Open filing evidence
2012-01-01 – 2012-12-31245105000 RestatedUSD20150218Open filing evidence
2011-01-01 – 2011-12-31267474000 USD20140303Open filing evidence

Ebioscience

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=affx:EbioscienceMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-12-3192494000 USD20150218Open filing evidence
2013-01-01 – 2013-12-3188949000 RestatedUSD20150218Open filing evidence
2012-01-01 – 2012-12-3150518000 RestatedUSD20150218Open filing evidence
2011-01-01 – 2011-12-310 USD20140303Open filing evidence

Total Revenue From Reportable Operating Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=affx:TotalRevenueFromReportableOperatingSegmentsMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-12-31272116000 U00120130304Open filing evidence
2011-01-01 – 2011-12-31242307000 U00120130304Open filing evidence

Unallocated Revenue To Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=affx:UnallocatedRevenueToSegmentMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-12-3123507000 U00120130304Open filing evidence
2011-01-01 – 2011-12-3125167000 U00120130304Open filing evidence